The 1998 guidelines on breast cancer follow-up has been updated by the American Society of Clinical Oncology. They state the most reliable way for detecting a recurrence is to receive physical exams and educating patients on the symptoms of recurrence.
All women should perform monthly breast exams. Genetic counseling is recommended for high risk women, including those with Askhenazi Jewish heritage, family history of breast or ovarian cancer, or diagnosis of bilateral breast cancer in the patient or relative.
Study results show no survival advantage for intensive verses conservative surveillance. Complete blood counts (CBCs), liver function tests, imaging studies, and assessment of tumor markers are not recommended for routine surveillance.
Breast cancer can recur within 15 years of the initial diagnoses and beyond, surveillance is a lifelong process for breast cancer survivors.
